SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForterra Regulatory News (FORT)

Share Price Information for Forterra (FORT)

Share Price is delayed by 15 minutes
Get Live Data
130.20    2.40 (1.88%)
Bid:
130.00
Ask:
130.40
Spread: 0.40 (0.308%)
Market Cap: £268.15m
FORT Live PriceLast checked at - London Stock Exchange

Intraday Forterra Share Chart

Update on Covid-19

24 Mar 2020 14:50

RNS Number : 4163H
Forterra plc
24 March 2020
 

FORTERRA plc

 

24 March 2020

 

Update on Covid-19

Forterra plc, a leading UK producer of manufactured masonry products, provides an update on Covid-19 and the measures it is taking to mitigate the impact on its business.

Colleagues and customers

The health, safety and wellbeing of our employees remains our primary concern and we have already taken prompt action to allow our colleagues to work from home wherever possible and eliminated all unnecessary travel.

In light of the new Government guidance, and in order to protect our workforce, the Board has decided to suspend all business operations as soon as possible until further notice. In some cases shutting down our facilities in a controlled and safe manner will take several days, and we will take all necessary measures to ensure our factories can efficiently resume production at the appropriate time.

The Board welcomes the Government's announcement that funding will be available to ensure employees can still be paid a proportion of their salary during a period of furlough and anticipates making use of this facility.

Balance sheet and liquidity

The Group enters this uncertain time with a strong balance sheet. We ended 2019 with net debt (pre IFRS 16) of £43.2m. This represents a multiple of 0.6 times EBITDA on a pre IFRS 16 basis.

The Group has access to a £150m revolving credit facility extending to July 2022. In recent days the Group has taken the precautionary action of drawing this facility. At the present time the Group has cash reserves of c£70m and access to an undrawn overdraft facility of £10m. In addition, the Group's credit agreement includes a £50m uncommitted accordion facility on the same terms as the main facility.

We are in regular discussion with the Company's lenders, all of whom remain supportive, to understand what future funding options may be available to the Company in light of recent Government announcements.

Actions

Given the unprecedented level of uncertainty we now face with significant economic disruption ahead, the Board has taken several immediate actions to protect the Group's liquidity position including:

Cost reduction and cash preservation: Prior to the decision to temporarily cease operations we had already taken actions to halt all non-essential discretionary expenditure. Existing commitments for capital expenditure will be honoured although we expect our suppliers and contractors to also face significant disruption in the coming months. No new commitments will be entered into. The Board remains committed to the completion of the new Desford brick factory although the phasing of expenditure will be flexed according to circumstance.

2019 final dividend suspended: Our recent full year results announcement stated that the Board would propose the payment of a final dividend of 7.5 pence per share. If approved by shareholders at the AGM this would lead to a cash outflow of c£15m in July. Whilst the Board recognises the importance of the dividend to shareholders, in the current circumstances the Board feels that it is no longer appropriate to make this payment and this resolution will be removed from the AGM notice sent to shareholders in the coming weeks.

At this stage the Board is unable to quantify what impact Covid-19 and the actions we are taking will have on the 2020 results and as such is currently unable to provide meaningful guidance on future earnings.

Upcoming AGM

The Company's AGM is currently scheduled for 14 May 2020. This is being kept under review and a further announcement will be made in due course.

Enquiries:

Forterra plc:

+44 (0) 1604 707 600

Stephen Harrison (CEO) / Ben Guyatt (CFO)

FTI Consulting:

+44 (0) 20 3727 1340

Richard Mountain/Nick Hasell

 

Further information relating to the Company and its group can be found at www.forterraplc.co.uk.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDUSSSRRWUOUAR
Date   Source Headline
11th Jun 20262:52 pmRNSGrant under Long Term Incentive Plan
11th Jun 20267:00 amRNSDirectorate change
9th Jun 202611:53 amRNSHolding(s) in Company
9th Jun 20267:00 amRNSTransaction in Own Shares
3rd Jun 20269:45 amRNSTransaction in Own Shares
2nd Jun 202612:32 pmRNSEmployee Benefit Trust Share Purchase
2nd Jun 202612:30 pmRNSTotal Voting Rights and Capital
1st Jun 20267:00 amRNSAppointment of New Independent NED
27th May 20267:00 amRNSTransaction in Own Shares
21st May 20265:03 pmRNSHolding(s) in Company
19th May 20264:41 pmRNSAnnual General Meeting 2026 Results
19th May 20267:01 amRNSTransaction in Own Shares
19th May 20267:00 amRNSAGM Trading Update
12th May 20261:32 pmRNSTransaction in Own Shares
12th May 20267:00 amRNSAGM RESOLUTION – APPROVAL OF REMUNERATION POLICY
7th May 20261:43 pmRNSHolding(s) in Company
6th May 202610:50 amRNSTransaction in Own Shares
6th May 20269:58 amRNSTotal Voting Rights and Capital
6th May 20269:55 amRNSEmployee Benefit Trust Share Purchase
28th Apr 202610:20 amRNSHolding(s) in Company
28th Apr 202610:18 amRNSTransaction in Own Shares
21st Apr 202611:31 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSEmployee Benefit Trust Share Purchase
15th Apr 20265:40 pmRNSNotice of Annual General Meeting 2026
14th Apr 202610:00 amRNSTransaction in Own Shares
14th Apr 20267:00 amRNSAppointment of new Independent NED
9th Apr 202610:15 amRNSHolding(s) in Company
9th Apr 20267:00 amRNSDirector Declaration
8th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20262:07 pmRNSTotal Voting Rights
7th Apr 202612:47 pmRNSEmployee Benefit Trust Share Purchase
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20261:03 pmRNSDirector / PCA Shareholdings
25th Mar 202610:50 amRNSAnnual Report and Accounts 2025
24th Mar 202610:40 amRNSTransaction in Own Shares
24th Mar 20269:01 amRNSHolding(s) in Company
24th Mar 20267:00 amRNSReplacement:Grant under Deferred Annual Bonus Plan
20th Mar 20268:45 amRNSGrant under Deferred Annual Bonus Plan
17th Mar 20267:00 amRNSEmployee Benefit Trust Share Purchase
17th Mar 20267:00 amRNSEmployee Benefit Trust Share Purchase
16th Mar 202610:32 amRNSLaunch of £20m Share Buyback Programme
16th Mar 202610:32 amRNSLaunch of £20m Share Buyback Programme
11th Mar 20267:00 amRNSFull Year Results
3rd Mar 20263:27 pmRNSEmployee Benefit Trust Share Purchase
18th Feb 20262:27 pmRNSEmployee Benefit Trust Share Purchase
3rd Feb 202612:26 pmRNSEmployee Benefit Trust Share Purchase
29th Jan 20268:33 amRNSHolding(s) in Company
28th Jan 20269:21 amRNSHolding(s) in Company
26th Jan 20264:07 pmRNSHolding(s) in Company
22nd Jan 20267:00 amRNSFull Year 2025 Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.